Results 151 to 160 of about 4,105,012 (242)

The First Swiss National Nutrition Survey in Children and Adolescents, menuCH-Kids: Study Design, Participants, and Data Quality. [PDF]

Int J Public Health
Vincentini J, Riou J, Häusermann T, Schwitzguebel J, Estoppey Younes S, Catalano L, Brombach C, Chaouch A, Chatelan A, Dratva J, Isler F, Müller P, Rezzi S, Righini-Grunder F, Rohrmann S, Saner C, Simonetti GD, Uhlmann K, Vanoni F, Zuberbuehler CA, Siegfried-Troxler A, Suggs S, van der Horst K, Bochud M.   +23 more
europepmc   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

Molecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang, Dong Jun Koo, Peter M. Tessier, Greg M. Thurber   +3 more
wiley   +1 more source

A Multi-Dimensional Framework for Data Quality Assurance in Cancer Imaging Repositories. [PDF]

Cancers (Basel)
Tsave O, Kosvyra A, Filos DT, Fotopoulos DT, Chouvarda I.   +4 more
europepmc   +1 more source

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

Molecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee, Byung‐Cheol Han, Gi‐Bang Koo, Jihye Park, Mijin Kwon, Young Bin Park, Jae‐Mun Choi, Seung‐Ho Lee, Sangho Roh   +8 more
wiley   +1 more source

Discovery of data quality issues in electronic health records: profound consequences for critical care medicine applications - a systematized review. [PDF]

Crit Care
de Andrade JBC, de Medeiros Cavalcante MAO, Lopes TLM, Treigher JMS, Balsells MD, Vasconcelos JL, Monteiro LC, da Silveira Mota DD.   +7 more
europepmc   +1 more source

Tumor mutational burden as a determinant of metastatic dissemination patterns

Molecular Oncology, EarlyView.
This study performed a comprehensive analysis of genomic data to elucidate whether metastasis in certain organs share genetic characteristics regardless of cancer type. No robust mutational patterns were identified across different metastatic locations and cancer types.
Eduardo Candeal, Andrea Moreno‐Manuel, Miguel Salvadó‐Pertierra, Cristina Santos‐Vivas, Rebeca Sanz‐Pamplona   +4 more
wiley   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

Molecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat, Aslihan Kucuk, Omer Erdogan, Samed Ozer, Bensu Kozan, Tugba Cuceli, Erkan Gumus, Evrim Cevik, Ozge Cevik   +8 more
wiley   +1 more source

Assessing Data Quality in Heterogeneous Health Care Integration: Simulation Study of the AIDAVA Framework. [PDF]

JMIR Med Inform
Declerck J, Kılıç ÖD, Emir Erol E, Mehryar S, Kalra D, de Zegher I, Celebi R.   +6 more
europepmc   +1 more source

The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity

Molecular Oncology, EarlyView.
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli, Alessio Bevilacqua, Mathias Wenes, Denis Migliorini, Lars van der Veen, Sigrid S Skånland, Giusy Di Conza, Kjetil Taskén   +7 more
wiley   +1 more source

Challenges of data quality for the management of prostate cancer in Tanzania: A hurdle towards improving the quality of service. [PDF]

PLOS Glob Public Health
Nyongole O, Munishi C, Kimu N, Sangeda RZ, Mseti M, Lugina E, Kiwara F, Sirili N, Chacha F, Nicholaus B, Frumence G, Simba D, Urassa D, Sunguya B.   +13 more
europepmc   +1 more source